Diabetes, Vol 40, Issue 12 1652-1658, Copyright © 1991 by American Diabetes Association

ARTICLES

Effects of chronic alpha-adrenergic receptor blockade on peripheral nerve conduction, hypoxic resistance, polyols, Na(+)-K(+)-ATPase activity, and vascular supply in STZ-D rats

NE Cameron, MA Cotter, K Ferguson, S Robertson and MA Radcliffe
School of Biomedical Sciences, University of Aberdeen, Scotland, United Kingdom.

The effects of alpha-receptor blockade on nerve conduction, hypoxic resistance, ouabain-sensitive Na(+)-K(+)-ATPase, nerve polyols, and capillary density were examined in streptozocin-induced diabetic (STZ-D) rats. Nondiabetic and untreated diabetic control groups were used. Diabetes duration was 2 mo. There were two treated diabetic groups. A "prevention" group received 5 mg/kg prazosin for 2 mo from the induction of diabetes. A "reversal" group was untreated for the 1st mo and was given prazosin for the subsequent month. Conduction was measured in motor nerves supplying tibialis anterior and gastrocnemius muscles and sensory saphenous nerve. Diabetes resulted in 15-29% reductions in conduction velocity (P less than 0.01). In the prevention group, conduction deficits were minimal compared with untreated diabetes (P less than 0.01). In the reversal group, motor conduction was also substantially improved, although sensory conduction was not significantly affected. In vitro measurement of sciatic nerve hypoxic resistance revealed a 49% increase in the time taken for compound action potential amplitude to reach half its initial value with diabetes (P less than 0.01). This was largely prevented by prazosin treatment (P less than 0.01), although treatment had a lesser effect in the reversal group. Treatment had no effect on nerve polyol levels or Na(+)-K(+)-ATPase activity. Functional improvements with prazosin were probably based on increased vasa nervorum perfusion. There was a 20% elevation of endoneurial capillary density (P less than 0.01) in both prevention and reversal groups. We conclude that vascular factors play an important role in the etiology of experimental diabetic neuropathy, and functional changes may be corrected by chronic vasodilator treatment.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. J. Stevens, W. Zhang, F. Li, and A. A. F. Sima C-peptide corrects endoneurial blood flow but not oxidative stress in type 1 BB/Wor rats Am J Physiol Endocrinol Metab, September 1, 2004; 287(3): E497 - E505. [Abstract] [Full Text] [PDF]

				M. A. Cotter, K. Ekberg, J. Wahren, and N. E. Cameron Effects of Proinsulin C-Peptide in Experimental Diabetic Neuropathy: Vascular Actions and Modulation by Nitric Oxide Synthase Inhibition Diabetes, July 1, 2003; 52(7): 1812 - 1817. [Abstract] [Full Text] [PDF]

				K. C.J. Yuen, N. R. Baker, and G. Rayman Treatment of Chronic Painful Diabetic Neuropathy With Isosorbide Dinitrate Spray: A double-blind placebo-controlled cross-over study Diabetes Care, October 1, 2002; 25(10): 1699 - 1703. [Abstract] [Full Text] [PDF]

				R. Pop-Busui, V. Marinescu, C. Van Huysen, F. Li, K. Sullivan, D. A. Greene, D. Larkin, and M. J. Stevens Dissection of Metabolic, Vascular, and Nerve Conduction Interrelationships in Experimental Diabetic Neuropathy by Cyclooxygenase Inhibition and Acetyl-L-Carnitine Administration Diabetes, August 1, 2002; 51(8): 2619 - 2628. [Abstract] [Full Text] [PDF]

				I. G. OBROSOVA, C. VAN HUYSEN, L. FATHALLAH, X. CAO, M. J. STEVENS, and D. A. GREENE Evaluation of {alpha}1-adrenoceptor antagonist on diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense FASEB J, August 1, 2000; 14(11): 1548 - 1558. [Abstract] [Full Text]

				R. J Head, P. L McLennan, D. Raederstorff, R. Muggli, S. L Burnard, and E. J McMurchie Prevention of nerve conduction deficit in diabetic rats by polyunsaturated fatty acids1 Am. J. Clinical Nutrition, January 1, 2000; 71(1): 386S - 392S. [Abstract] [Full Text] [PDF]

				P Lindstrom, U Lindblom, and T Brismar Delayed recovery of nerve conduction and vibratory sensibility after ischaemic block in patients with diabetes mellitus J. Neurol. Neurosurg. Psychiatry, September 1, 1997; 63(3): 346 - 350. [Abstract] [Full Text] [PDF]